Global Antiviral Drugs Market Growth 2025-2031
The global Antiviral Drugs market size is predicted to grow from US$ 1787 million in 2025 to US$ 2392 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
LP Information, Inc. (LPI) ' newest research report, the “Antiviral Drugs Industry Forecast” looks at past sales and reviews total world Antiviral Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Antiviral Drugs sales for 2025 through 2031. With Antiviral Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiviral Drugs industry.
This Insight Report provides a comprehensive analysis of the global Antiviral Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antiviral Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiviral Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiviral Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiviral Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiviral Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antiviral Drugs market?
What factors are driving Antiviral Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antiviral Drugs market opportunities vary by end market size?
How does Antiviral Drugs break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
LP Information, Inc. (LPI) ' newest research report, the “Antiviral Drugs Industry Forecast” looks at past sales and reviews total world Antiviral Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Antiviral Drugs sales for 2025 through 2031. With Antiviral Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiviral Drugs industry.
This Insight Report provides a comprehensive analysis of the global Antiviral Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antiviral Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiviral Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiviral Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiviral Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiviral Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Fusion Inhibitors
- Immune System Modulators
- Hepatitis Therapeutics
- HIV/AIDS Therapeutics
- Herpes Therapeutics
- Influenza Therapeutics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Johnson & Johnson
- Merck
- Novartis
- Bristol-Myers Squibb
- Gilead Sciences
- GlaxoSmithKline
- AbbVie
What is the 10-year outlook for the global Antiviral Drugs market?
What factors are driving Antiviral Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antiviral Drugs market opportunities vary by end market size?
How does Antiviral Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mechanical Wrist Watches Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mechanical Wrist Watches by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mechanical Wrist Watches by Country/Region, 2020, 2024 & 2031
2.2 Mechanical Wrist Watches Segment by Type
2.2.1 Luxury Watches
2.2.2 Common Watches
2.3 Mechanical Wrist Watches Sales by Type
2.3.1 Global Mechanical Wrist Watches Sales Market Share by Type (2020-2025)
2.3.2 Global Mechanical Wrist Watches Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mechanical Wrist Watches Sale Price by Type (2020-2025)
2.4 Mechanical Wrist Watches Segment by Application
2.4.1 Daliy Use
2.4.2 Collection
2.4.3 Others
2.5 Mechanical Wrist Watches Sales by Application
2.5.1 Global Mechanical Wrist Watches Sale Market Share by Application (2020-2025)
2.5.2 Global Mechanical Wrist Watches Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mechanical Wrist Watches Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mechanical Wrist Watches Breakdown Data by Company
3.1.1 Global Mechanical Wrist Watches Annual Sales by Company (2020-2025)
3.1.2 Global Mechanical Wrist Watches Sales Market Share by Company (2020-2025)
3.2 Global Mechanical Wrist Watches Annual Revenue by Company (2020-2025)
3.2.1 Global Mechanical Wrist Watches Revenue by Company (2020-2025)
3.2.2 Global Mechanical Wrist Watches Revenue Market Share by Company (2020-2025)
3.3 Global Mechanical Wrist Watches Sale Price by Company
3.4 Key Manufacturers Mechanical Wrist Watches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mechanical Wrist Watches Product Location Distribution
3.4.2 Players Mechanical Wrist Watches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MECHANICAL WRIST WATCHES BY GEOGRAPHIC REGION
4.1 World Historic Mechanical Wrist Watches Market Size by Geographic Region (2020-2025)
4.1.1 Global Mechanical Wrist Watches Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mechanical Wrist Watches Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mechanical Wrist Watches Market Size by Country/Region (2020-2025)
4.2.1 Global Mechanical Wrist Watches Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mechanical Wrist Watches Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mechanical Wrist Watches Sales Growth
4.4 APAC Mechanical Wrist Watches Sales Growth
4.5 Europe Mechanical Wrist Watches Sales Growth
4.6 Middle East & Africa Mechanical Wrist Watches Sales Growth
5 AMERICAS
5.1 Americas Mechanical Wrist Watches Sales by Country
5.1.1 Americas Mechanical Wrist Watches Sales by Country (2020-2025)
5.1.2 Americas Mechanical Wrist Watches Revenue by Country (2020-2025)
5.2 Americas Mechanical Wrist Watches Sales by Type (2020-2025)
5.3 Americas Mechanical Wrist Watches Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mechanical Wrist Watches Sales by Region
6.1.1 APAC Mechanical Wrist Watches Sales by Region (2020-2025)
6.1.2 APAC Mechanical Wrist Watches Revenue by Region (2020-2025)
6.2 APAC Mechanical Wrist Watches Sales by Type (2020-2025)
6.3 APAC Mechanical Wrist Watches Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mechanical Wrist Watches by Country
7.1.1 Europe Mechanical Wrist Watches Sales by Country (2020-2025)
7.1.2 Europe Mechanical Wrist Watches Revenue by Country (2020-2025)
7.2 Europe Mechanical Wrist Watches Sales by Type (2020-2025)
7.3 Europe Mechanical Wrist Watches Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mechanical Wrist Watches by Country
8.1.1 Middle East & Africa Mechanical Wrist Watches Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mechanical Wrist Watches Revenue by Country (2020-2025)
8.2 Middle East & Africa Mechanical Wrist Watches Sales by Type (2020-2025)
8.3 Middle East & Africa Mechanical Wrist Watches Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mechanical Wrist Watches
10.3 Manufacturing Process Analysis of Mechanical Wrist Watches
10.4 Industry Chain Structure of Mechanical Wrist Watches
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mechanical Wrist Watches Distributors
11.3 Mechanical Wrist Watches Customer
12 WORLD FORECAST REVIEW FOR MECHANICAL WRIST WATCHES BY GEOGRAPHIC REGION
12.1 Global Mechanical Wrist Watches Market Size Forecast by Region
12.1.1 Global Mechanical Wrist Watches Forecast by Region (2026-2031)
12.1.2 Global Mechanical Wrist Watches Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mechanical Wrist Watches Forecast by Type (2026-2031)
12.7 Global Mechanical Wrist Watches Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Swatch Group
13.1.1 Swatch Group Company Information
13.1.2 Swatch Group Mechanical Wrist Watches Product Portfolios and Specifications
13.1.3 Swatch Group Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Swatch Group Main Business Overview
13.1.5 Swatch Group Latest Developments
13.2 Rolex
13.2.1 Rolex Company Information
13.2.2 Rolex Mechanical Wrist Watches Product Portfolios and Specifications
13.2.3 Rolex Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rolex Main Business Overview
13.2.5 Rolex Latest Developments
13.3 Richemont
13.3.1 Richemont Company Information
13.3.2 Richemont Mechanical Wrist Watches Product Portfolios and Specifications
13.3.3 Richemont Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Richemont Main Business Overview
13.3.5 Richemont Latest Developments
13.4 LVMH
13.4.1 LVMH Company Information
13.4.2 LVMH Mechanical Wrist Watches Product Portfolios and Specifications
13.4.3 LVMH Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 LVMH Main Business Overview
13.4.5 LVMH Latest Developments
13.5 Fossil
13.5.1 Fossil Company Information
13.5.2 Fossil Mechanical Wrist Watches Product Portfolios and Specifications
13.5.3 Fossil Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fossil Main Business Overview
13.5.5 Fossil Latest Developments
13.6 Citizen
13.6.1 Citizen Company Information
13.6.2 Citizen Mechanical Wrist Watches Product Portfolios and Specifications
13.6.3 Citizen Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Citizen Main Business Overview
13.6.5 Citizen Latest Developments
13.7 Seiko
13.7.1 Seiko Company Information
13.7.2 Seiko Mechanical Wrist Watches Product Portfolios and Specifications
13.7.3 Seiko Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Seiko Main Business Overview
13.7.5 Seiko Latest Developments
13.8 Patek Philippe
13.8.1 Patek Philippe Company Information
13.8.2 Patek Philippe Mechanical Wrist Watches Product Portfolios and Specifications
13.8.3 Patek Philippe Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Patek Philippe Main Business Overview
13.8.5 Patek Philippe Latest Developments
13.9 Casio
13.9.1 Casio Company Information
13.9.2 Casio Mechanical Wrist Watches Product Portfolios and Specifications
13.9.3 Casio Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Casio Main Business Overview
13.9.5 Casio Latest Developments
13.10 Chopard
13.10.1 Chopard Company Information
13.10.2 Chopard Mechanical Wrist Watches Product Portfolios and Specifications
13.10.3 Chopard Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Chopard Main Business Overview
13.10.5 Chopard Latest Developments
13.11 Audemars Piguet
13.11.1 Audemars Piguet Company Information
13.11.2 Audemars Piguet Mechanical Wrist Watches Product Portfolios and Specifications
13.11.3 Audemars Piguet Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Audemars Piguet Main Business Overview
13.11.5 Audemars Piguet Latest Developments
13.12 Movado Group
13.12.1 Movado Group Company Information
13.12.2 Movado Group Mechanical Wrist Watches Product Portfolios and Specifications
13.12.3 Movado Group Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Movado Group Main Business Overview
13.12.5 Movado Group Latest Developments
13.13 Kering
13.13.1 Kering Company Information
13.13.2 Kering Mechanical Wrist Watches Product Portfolios and Specifications
13.13.3 Kering Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Kering Main Business Overview
13.13.5 Kering Latest Developments
13.14 Breitling
13.14.1 Breitling Company Information
13.14.2 Breitling Mechanical Wrist Watches Product Portfolios and Specifications
13.14.3 Breitling Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Breitling Main Business Overview
13.14.5 Breitling Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mechanical Wrist Watches Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mechanical Wrist Watches by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mechanical Wrist Watches by Country/Region, 2020, 2024 & 2031
2.2 Mechanical Wrist Watches Segment by Type
2.2.1 Luxury Watches
2.2.2 Common Watches
2.3 Mechanical Wrist Watches Sales by Type
2.3.1 Global Mechanical Wrist Watches Sales Market Share by Type (2020-2025)
2.3.2 Global Mechanical Wrist Watches Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mechanical Wrist Watches Sale Price by Type (2020-2025)
2.4 Mechanical Wrist Watches Segment by Application
2.4.1 Daliy Use
2.4.2 Collection
2.4.3 Others
2.5 Mechanical Wrist Watches Sales by Application
2.5.1 Global Mechanical Wrist Watches Sale Market Share by Application (2020-2025)
2.5.2 Global Mechanical Wrist Watches Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mechanical Wrist Watches Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mechanical Wrist Watches Breakdown Data by Company
3.1.1 Global Mechanical Wrist Watches Annual Sales by Company (2020-2025)
3.1.2 Global Mechanical Wrist Watches Sales Market Share by Company (2020-2025)
3.2 Global Mechanical Wrist Watches Annual Revenue by Company (2020-2025)
3.2.1 Global Mechanical Wrist Watches Revenue by Company (2020-2025)
3.2.2 Global Mechanical Wrist Watches Revenue Market Share by Company (2020-2025)
3.3 Global Mechanical Wrist Watches Sale Price by Company
3.4 Key Manufacturers Mechanical Wrist Watches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mechanical Wrist Watches Product Location Distribution
3.4.2 Players Mechanical Wrist Watches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MECHANICAL WRIST WATCHES BY GEOGRAPHIC REGION
4.1 World Historic Mechanical Wrist Watches Market Size by Geographic Region (2020-2025)
4.1.1 Global Mechanical Wrist Watches Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mechanical Wrist Watches Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mechanical Wrist Watches Market Size by Country/Region (2020-2025)
4.2.1 Global Mechanical Wrist Watches Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mechanical Wrist Watches Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mechanical Wrist Watches Sales Growth
4.4 APAC Mechanical Wrist Watches Sales Growth
4.5 Europe Mechanical Wrist Watches Sales Growth
4.6 Middle East & Africa Mechanical Wrist Watches Sales Growth
5 AMERICAS
5.1 Americas Mechanical Wrist Watches Sales by Country
5.1.1 Americas Mechanical Wrist Watches Sales by Country (2020-2025)
5.1.2 Americas Mechanical Wrist Watches Revenue by Country (2020-2025)
5.2 Americas Mechanical Wrist Watches Sales by Type (2020-2025)
5.3 Americas Mechanical Wrist Watches Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mechanical Wrist Watches Sales by Region
6.1.1 APAC Mechanical Wrist Watches Sales by Region (2020-2025)
6.1.2 APAC Mechanical Wrist Watches Revenue by Region (2020-2025)
6.2 APAC Mechanical Wrist Watches Sales by Type (2020-2025)
6.3 APAC Mechanical Wrist Watches Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mechanical Wrist Watches by Country
7.1.1 Europe Mechanical Wrist Watches Sales by Country (2020-2025)
7.1.2 Europe Mechanical Wrist Watches Revenue by Country (2020-2025)
7.2 Europe Mechanical Wrist Watches Sales by Type (2020-2025)
7.3 Europe Mechanical Wrist Watches Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mechanical Wrist Watches by Country
8.1.1 Middle East & Africa Mechanical Wrist Watches Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mechanical Wrist Watches Revenue by Country (2020-2025)
8.2 Middle East & Africa Mechanical Wrist Watches Sales by Type (2020-2025)
8.3 Middle East & Africa Mechanical Wrist Watches Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mechanical Wrist Watches
10.3 Manufacturing Process Analysis of Mechanical Wrist Watches
10.4 Industry Chain Structure of Mechanical Wrist Watches
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mechanical Wrist Watches Distributors
11.3 Mechanical Wrist Watches Customer
12 WORLD FORECAST REVIEW FOR MECHANICAL WRIST WATCHES BY GEOGRAPHIC REGION
12.1 Global Mechanical Wrist Watches Market Size Forecast by Region
12.1.1 Global Mechanical Wrist Watches Forecast by Region (2026-2031)
12.1.2 Global Mechanical Wrist Watches Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mechanical Wrist Watches Forecast by Type (2026-2031)
12.7 Global Mechanical Wrist Watches Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Swatch Group
13.1.1 Swatch Group Company Information
13.1.2 Swatch Group Mechanical Wrist Watches Product Portfolios and Specifications
13.1.3 Swatch Group Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Swatch Group Main Business Overview
13.1.5 Swatch Group Latest Developments
13.2 Rolex
13.2.1 Rolex Company Information
13.2.2 Rolex Mechanical Wrist Watches Product Portfolios and Specifications
13.2.3 Rolex Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rolex Main Business Overview
13.2.5 Rolex Latest Developments
13.3 Richemont
13.3.1 Richemont Company Information
13.3.2 Richemont Mechanical Wrist Watches Product Portfolios and Specifications
13.3.3 Richemont Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Richemont Main Business Overview
13.3.5 Richemont Latest Developments
13.4 LVMH
13.4.1 LVMH Company Information
13.4.2 LVMH Mechanical Wrist Watches Product Portfolios and Specifications
13.4.3 LVMH Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 LVMH Main Business Overview
13.4.5 LVMH Latest Developments
13.5 Fossil
13.5.1 Fossil Company Information
13.5.2 Fossil Mechanical Wrist Watches Product Portfolios and Specifications
13.5.3 Fossil Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fossil Main Business Overview
13.5.5 Fossil Latest Developments
13.6 Citizen
13.6.1 Citizen Company Information
13.6.2 Citizen Mechanical Wrist Watches Product Portfolios and Specifications
13.6.3 Citizen Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Citizen Main Business Overview
13.6.5 Citizen Latest Developments
13.7 Seiko
13.7.1 Seiko Company Information
13.7.2 Seiko Mechanical Wrist Watches Product Portfolios and Specifications
13.7.3 Seiko Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Seiko Main Business Overview
13.7.5 Seiko Latest Developments
13.8 Patek Philippe
13.8.1 Patek Philippe Company Information
13.8.2 Patek Philippe Mechanical Wrist Watches Product Portfolios and Specifications
13.8.3 Patek Philippe Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Patek Philippe Main Business Overview
13.8.5 Patek Philippe Latest Developments
13.9 Casio
13.9.1 Casio Company Information
13.9.2 Casio Mechanical Wrist Watches Product Portfolios and Specifications
13.9.3 Casio Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Casio Main Business Overview
13.9.5 Casio Latest Developments
13.10 Chopard
13.10.1 Chopard Company Information
13.10.2 Chopard Mechanical Wrist Watches Product Portfolios and Specifications
13.10.3 Chopard Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Chopard Main Business Overview
13.10.5 Chopard Latest Developments
13.11 Audemars Piguet
13.11.1 Audemars Piguet Company Information
13.11.2 Audemars Piguet Mechanical Wrist Watches Product Portfolios and Specifications
13.11.3 Audemars Piguet Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Audemars Piguet Main Business Overview
13.11.5 Audemars Piguet Latest Developments
13.12 Movado Group
13.12.1 Movado Group Company Information
13.12.2 Movado Group Mechanical Wrist Watches Product Portfolios and Specifications
13.12.3 Movado Group Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Movado Group Main Business Overview
13.12.5 Movado Group Latest Developments
13.13 Kering
13.13.1 Kering Company Information
13.13.2 Kering Mechanical Wrist Watches Product Portfolios and Specifications
13.13.3 Kering Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Kering Main Business Overview
13.13.5 Kering Latest Developments
13.14 Breitling
13.14.1 Breitling Company Information
13.14.2 Breitling Mechanical Wrist Watches Product Portfolios and Specifications
13.14.3 Breitling Mechanical Wrist Watches Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Breitling Main Business Overview
13.14.5 Breitling Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antiviral Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antiviral Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Reverse Transcriptase Inhibitors
Table 4. Major Players of Protease Inhibitors
Table 5. Major Players of Fusion Inhibitors
Table 6. Major Players of Immune System Modulators
Table 7. Global Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 8. Global Antiviral Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Antiviral Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Antiviral Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Antiviral Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Antiviral Drugs Sale by Application (2020-2025) & (K Units)
Table 13. Global Antiviral Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Antiviral Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Antiviral Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Antiviral Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Antiviral Drugs Sales by Company (2020-2025) & (K Units)
Table 18. Global Antiviral Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Antiviral Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Antiviral Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Antiviral Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Antiviral Drugs Producing Area Distribution and Sales Area
Table 23. Players Antiviral Drugs Products Offered
Table 24. Antiviral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Antiviral Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Antiviral Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Antiviral Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Antiviral Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Antiviral Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Antiviral Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Antiviral Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Antiviral Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Antiviral Drugs Sales by Country (2020-2025) & (K Units)
Table 36. Americas Antiviral Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Antiviral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 39. Americas Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 40. APAC Antiviral Drugs Sales by Region (2020-2025) & (K Units)
Table 41. APAC Antiviral Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Antiviral Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 44. APAC Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 45. Europe Antiviral Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Antiviral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 48. Europe Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Antiviral Drugs Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Antiviral Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Antiviral Drugs
Table 54. Key Market Challenges & Risks of Antiviral Drugs
Table 55. Key Industry Trends of Antiviral Drugs
Table 56. Antiviral Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Antiviral Drugs Distributors List
Table 59. Antiviral Drugs Customer List
Table 60. Global Antiviral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Antiviral Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Antiviral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Antiviral Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Antiviral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Antiviral Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Antiviral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Antiviral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Antiviral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Antiviral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Antiviral Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Antiviral Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Antiviral Drugs Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Antiviral Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Roche Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Roche Antiviral Drugs Product Portfolios and Specifications
Table 76. Roche Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Johnson & Johnson Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson & Johnson Antiviral Drugs Product Portfolios and Specifications
Table 81. Johnson & Johnson Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. Merck Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Antiviral Drugs Product Portfolios and Specifications
Table 86. Merck Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Novartis Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis Antiviral Drugs Product Portfolios and Specifications
Table 91. Novartis Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. Bristol-Myers Squibb Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Squibb Antiviral Drugs Product Portfolios and Specifications
Table 96. Bristol-Myers Squibb Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Latest Developments
Table 99. Gilead Sciences Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Gilead Sciences Antiviral Drugs Product Portfolios and Specifications
Table 101. Gilead Sciences Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Gilead Sciences Main Business
Table 103. Gilead Sciences Latest Developments
Table 104. GlaxoSmithKline Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. GlaxoSmithKline Antiviral Drugs Product Portfolios and Specifications
Table 106. GlaxoSmithKline Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. GlaxoSmithKline Main Business
Table 108. GlaxoSmithKline Latest Developments
Table 109. AbbVie Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. AbbVie Antiviral Drugs Product Portfolios and Specifications
Table 111. AbbVie Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. AbbVie Main Business
Table 113. AbbVie Latest Developments
Table 1. Antiviral Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antiviral Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Reverse Transcriptase Inhibitors
Table 4. Major Players of Protease Inhibitors
Table 5. Major Players of Fusion Inhibitors
Table 6. Major Players of Immune System Modulators
Table 7. Global Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 8. Global Antiviral Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Antiviral Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Antiviral Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Antiviral Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Antiviral Drugs Sale by Application (2020-2025) & (K Units)
Table 13. Global Antiviral Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Antiviral Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Antiviral Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Antiviral Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Antiviral Drugs Sales by Company (2020-2025) & (K Units)
Table 18. Global Antiviral Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Antiviral Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Antiviral Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Antiviral Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Antiviral Drugs Producing Area Distribution and Sales Area
Table 23. Players Antiviral Drugs Products Offered
Table 24. Antiviral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Antiviral Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Antiviral Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Antiviral Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Antiviral Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Antiviral Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Antiviral Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Antiviral Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Antiviral Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Antiviral Drugs Sales by Country (2020-2025) & (K Units)
Table 36. Americas Antiviral Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Antiviral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 39. Americas Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 40. APAC Antiviral Drugs Sales by Region (2020-2025) & (K Units)
Table 41. APAC Antiviral Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Antiviral Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 44. APAC Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 45. Europe Antiviral Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Antiviral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 48. Europe Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Antiviral Drugs Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Antiviral Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Antiviral Drugs Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Antiviral Drugs Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Antiviral Drugs
Table 54. Key Market Challenges & Risks of Antiviral Drugs
Table 55. Key Industry Trends of Antiviral Drugs
Table 56. Antiviral Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Antiviral Drugs Distributors List
Table 59. Antiviral Drugs Customer List
Table 60. Global Antiviral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Antiviral Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Antiviral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Antiviral Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Antiviral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Antiviral Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Antiviral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Antiviral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Antiviral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Antiviral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Antiviral Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Antiviral Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Antiviral Drugs Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Antiviral Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Roche Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Roche Antiviral Drugs Product Portfolios and Specifications
Table 76. Roche Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Johnson & Johnson Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson & Johnson Antiviral Drugs Product Portfolios and Specifications
Table 81. Johnson & Johnson Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. Merck Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Antiviral Drugs Product Portfolios and Specifications
Table 86. Merck Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Novartis Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis Antiviral Drugs Product Portfolios and Specifications
Table 91. Novartis Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. Bristol-Myers Squibb Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Squibb Antiviral Drugs Product Portfolios and Specifications
Table 96. Bristol-Myers Squibb Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Latest Developments
Table 99. Gilead Sciences Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Gilead Sciences Antiviral Drugs Product Portfolios and Specifications
Table 101. Gilead Sciences Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Gilead Sciences Main Business
Table 103. Gilead Sciences Latest Developments
Table 104. GlaxoSmithKline Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. GlaxoSmithKline Antiviral Drugs Product Portfolios and Specifications
Table 106. GlaxoSmithKline Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. GlaxoSmithKline Main Business
Table 108. GlaxoSmithKline Latest Developments
Table 109. AbbVie Basic Information, Antiviral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. AbbVie Antiviral Drugs Product Portfolios and Specifications
Table 111. AbbVie Antiviral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. AbbVie Main Business
Table 113. AbbVie Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antiviral Drugs
Figure 2. Antiviral Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiviral Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Antiviral Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antiviral Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antiviral Drugs Sales Market Share by Country/Region (2024)
Figure 10. Antiviral Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Reverse Transcriptase Inhibitors
Figure 12. Product Picture of Protease Inhibitors
Figure 13. Product Picture of Fusion Inhibitors
Figure 14. Product Picture of Immune System Modulators
Figure 15. Global Antiviral Drugs Sales Market Share by Type in 2025
Figure 16. Global Antiviral Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Antiviral Drugs Consumed in Hepatitis Therapeutics
Figure 18. Global Antiviral Drugs Market: Hepatitis Therapeutics (2020-2025) & (K Units)
Figure 19. Antiviral Drugs Consumed in HIV/AIDS Therapeutics
Figure 20. Global Antiviral Drugs Market: HIV/AIDS Therapeutics (2020-2025) & (K Units)
Figure 21. Antiviral Drugs Consumed in Herpes Therapeutics
Figure 22. Global Antiviral Drugs Market: Herpes Therapeutics (2020-2025) & (K Units)
Figure 23. Antiviral Drugs Consumed in Influenza Therapeutics
Figure 24. Global Antiviral Drugs Market: Influenza Therapeutics (2020-2025) & (K Units)
Figure 25. Global Antiviral Drugs Sale Market Share by Application (2024)
Figure 26. Global Antiviral Drugs Revenue Market Share by Application in 2025
Figure 27. Antiviral Drugs Sales by Company in 2025 (K Units)
Figure 28. Global Antiviral Drugs Sales Market Share by Company in 2025
Figure 29. Antiviral Drugs Revenue by Company in 2025 ($ millions)
Figure 30. Global Antiviral Drugs Revenue Market Share by Company in 2025
Figure 31. Global Antiviral Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Antiviral Drugs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Antiviral Drugs Sales 2020-2025 (K Units)
Figure 34. Americas Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 35. APAC Antiviral Drugs Sales 2020-2025 (K Units)
Figure 36. APAC Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 37. Europe Antiviral Drugs Sales 2020-2025 (K Units)
Figure 38. Europe Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Antiviral Drugs Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 41. Americas Antiviral Drugs Sales Market Share by Country in 2025
Figure 42. Americas Antiviral Drugs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 44. Americas Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 45. United States Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Antiviral Drugs Sales Market Share by Region in 2025
Figure 50. APAC Antiviral Drugs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 52. APAC Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 53. China Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Antiviral Drugs Sales Market Share by Country in 2025
Figure 61. Europe Antiviral Drugs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 63. Europe Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 64. Germany Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. France Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Antiviral Drugs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Antiviral Drugs in 2025
Figure 78. Manufacturing Process Analysis of Antiviral Drugs
Figure 79. Industry Chain Structure of Antiviral Drugs
Figure 80. Channels of Distribution
Figure 81. Global Antiviral Drugs Sales Market Forecast by Region (2026-2031)
Figure 82. Global Antiviral Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Antiviral Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Antiviral Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Antiviral Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Antiviral Drugs Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Antiviral Drugs
Figure 2. Antiviral Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiviral Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Antiviral Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antiviral Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antiviral Drugs Sales Market Share by Country/Region (2024)
Figure 10. Antiviral Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Reverse Transcriptase Inhibitors
Figure 12. Product Picture of Protease Inhibitors
Figure 13. Product Picture of Fusion Inhibitors
Figure 14. Product Picture of Immune System Modulators
Figure 15. Global Antiviral Drugs Sales Market Share by Type in 2025
Figure 16. Global Antiviral Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Antiviral Drugs Consumed in Hepatitis Therapeutics
Figure 18. Global Antiviral Drugs Market: Hepatitis Therapeutics (2020-2025) & (K Units)
Figure 19. Antiviral Drugs Consumed in HIV/AIDS Therapeutics
Figure 20. Global Antiviral Drugs Market: HIV/AIDS Therapeutics (2020-2025) & (K Units)
Figure 21. Antiviral Drugs Consumed in Herpes Therapeutics
Figure 22. Global Antiviral Drugs Market: Herpes Therapeutics (2020-2025) & (K Units)
Figure 23. Antiviral Drugs Consumed in Influenza Therapeutics
Figure 24. Global Antiviral Drugs Market: Influenza Therapeutics (2020-2025) & (K Units)
Figure 25. Global Antiviral Drugs Sale Market Share by Application (2024)
Figure 26. Global Antiviral Drugs Revenue Market Share by Application in 2025
Figure 27. Antiviral Drugs Sales by Company in 2025 (K Units)
Figure 28. Global Antiviral Drugs Sales Market Share by Company in 2025
Figure 29. Antiviral Drugs Revenue by Company in 2025 ($ millions)
Figure 30. Global Antiviral Drugs Revenue Market Share by Company in 2025
Figure 31. Global Antiviral Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Antiviral Drugs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Antiviral Drugs Sales 2020-2025 (K Units)
Figure 34. Americas Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 35. APAC Antiviral Drugs Sales 2020-2025 (K Units)
Figure 36. APAC Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 37. Europe Antiviral Drugs Sales 2020-2025 (K Units)
Figure 38. Europe Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Antiviral Drugs Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Antiviral Drugs Revenue 2020-2025 ($ millions)
Figure 41. Americas Antiviral Drugs Sales Market Share by Country in 2025
Figure 42. Americas Antiviral Drugs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 44. Americas Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 45. United States Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Antiviral Drugs Sales Market Share by Region in 2025
Figure 50. APAC Antiviral Drugs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 52. APAC Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 53. China Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Antiviral Drugs Sales Market Share by Country in 2025
Figure 61. Europe Antiviral Drugs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 63. Europe Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 64. Germany Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. France Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Antiviral Drugs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Antiviral Drugs Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Antiviral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Antiviral Drugs in 2025
Figure 78. Manufacturing Process Analysis of Antiviral Drugs
Figure 79. Industry Chain Structure of Antiviral Drugs
Figure 80. Channels of Distribution
Figure 81. Global Antiviral Drugs Sales Market Forecast by Region (2026-2031)
Figure 82. Global Antiviral Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Antiviral Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Antiviral Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Antiviral Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Antiviral Drugs Revenue Market Share Forecast by Application (2026-2031)
